SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Leadership team appointments
Professor Christopher Sweeney has been appointed Director of SAiGENCI. Professor Sweeney is already actively engaged in driving SAiGENCI’s strategic direction and will visit Adelaide regularly during 2022 as Director Designate. He is expected to take up the position full time in late 2022 or early 2023.